Specific inhibitors of HCV polymerase identified using an NS5B with lower affinity for template/primer substrate

By McKercher Ginette   Beaulieu Pierre L.  

Nucleic Acids Research, Vol. 32, Iss. 2, 2004-01 ,pp. : 422-431

Oxford University Press

Access to resources Recommend Favorite

Non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase: discovery of benzimidazole 5-carboxylic amide derivatives with low-nanomolar potency

By Beaulieu P.L.   Bos M.   Bousquet Y.   DeRoy P.   Fazal G.   Gauthier J.   Gillard J.   Goulet S.   McKercher G.   Poupart M.-A.   Valois S.   Kukolj G.  

Bioorganic and Medicinal Chemistry Letters, Vol. 14, Iss. 4, 2004-02 ,pp. : 967-971

Elsevier

Access to resources Recommend Favorite

Structural Characterization of the Interactions of Optimized Product Inhibitors with the N-terminal Proteinase Domain of the Hepatitis C Virus (HCV) NS3 Protein by NMR and Modelling Studies

By Cicero D.O.   Barbato G.   Koch U.   Ingallinella P.   Bianchi E.   Nardi M.C.   Steinkühler C.   Cortese R.   Matassa V.   de Francesco R.   Pessi A.   Bazzo R.  

Journal of Molecular Biology, Vol. 289, Iss. 2, 1999-06 ,pp. : 385-396

Academic Press

Access to resources Recommend Favorite

Preclinical pharmacokinetics and metabolism of a potent non-nucleoside inhibitor of the hepatitis C virus NS5B polymerase

By Giuliano C.   Fiore F.   Di Marco A.   Padron Velazquez J.   Bishop A.   Bonelli F.   Gonzalez-paz O.   Marcucci I.   Harper S.   Narjes F.   Pacini B.   Monteagudo E.   Migliaccio G.   Rowley M.   Laufer R.  

Xenobiotica, Vol. 35, Iss. 10-11, 2005-10 ,pp. : 1035-1054

Informa Healthcare

Access to resources Recommend Favorite

Expression, Purification, and Partial Characterization of HCV RNA Polymerase

By Yuan Z.H.   Kumar U.   Thomas H.C.   Wen Y.M.   Monjardino J.  

Biochemical and Biophysical Research Communications, Vol. 232, Iss. 1, 1997-03 ,pp. : 231-235

Elsevier

Access to resources Recommend Favorite